Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Class A and Class B common stock and Common stock
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2020 40,842,619        
Beginning balance at Dec. 31, 2020 $ 231,503        
Ending balance (in shares) at Mar. 31, 2021 40,842,619        
Ending balance at Mar. 31, 2021 $ 231,503        
Beginning balance (in shares) at Dec. 31, 2020   24,185,622      
Beginning balance at Dec. 31, 2020 (190,178) $ 24 $ 20,602 $ 5,253 $ (216,057)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 1,524   1,524    
Exercise of common stock options (in shares)   591,000      
Exercise of common stock options 1,658 $ 1 1,657    
Unrealized loss on available-for-sale securities (15)     (15)  
Foreign currency translation adjustment (695)     (695)  
Net loss (10,086)       (10,086)
Ending balance (in shares) at Mar. 31, 2021   24,776,622      
Ending balance at Mar. 31, 2021 $ (197,792) $ 25 23,783 4,543 (226,143)
Beginning balance (in shares) at Dec. 31, 2021 0        
Beginning balance at Dec. 31, 2021 $ 0        
Ending balance (in shares) at Mar. 31, 2022 0        
Ending balance at Mar. 31, 2022 $ 0        
Beginning balance (in shares) at Dec. 31, 2021   82,648,825      
Beginning balance at Dec. 31, 2021 336,126 $ 83 593,196 6,672 (263,825)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense $ 6,460   6,460    
Exercise of common stock options (in shares) 1,602,727 1,602,727      
Exercise of common stock options $ 2,179 $ 1 2,178    
Unrealized loss on available-for-sale securities (1,686)     (1,686)  
Foreign currency translation adjustment (292)     (292)  
Net loss (16,470)       (16,470)
Ending balance (in shares) at Mar. 31, 2022   84,251,552      
Ending balance at Mar. 31, 2022 $ 326,317 $ 84 $ 601,834 $ 4,694 $ (280,295)